![A roadmap for designing better immunotherapies – Cancer Research Institute](https://oncodaily.com/pub/uploads/2024/09/c2iJ8Ed2xpXhDzITED1n-e1725500151409.png)
Sep 11, 2024, 07:24
A roadmap for designing better immunotherapies – Cancer Research Institute
Cancer Research Institute (CRI) made the following post on LinkedIn:
“New findings from researchers, including 2022 William B. Coley Award recipient Dr. Judy Lieberman of Boston Children’s Hospital, indicate that tumors edit multiple genes to avoid recognition by the immune system. Published in Springer Nature Group’s Nature Immunology, the study additionally demonstrates a way to override these edits, by curbing tumor growth in a human-like mouse model of breast cancer, ‘which is notoriously resistant to immunotherapy.’ Discover how this study could provide a roadmap for designing better immunotherapies.”
Read further.
Source: Cancer Research Institute (CRI)/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 11, 2024, 07:24
Sep 11, 2024, 06:51
Sep 11, 2024, 06:41
Sep 11, 2024, 05:25
Sep 11, 2024, 04:28
Sep 11, 2024, 01:59